✦ LIBER ✦

Indirect meta-analysis of randomised placebo-controlled clinical trials on rasagiline and selegiline in the symptomatic treatment of Parkinson’s disease

✍ Scribed by Wolfgang H. Jost; Michael Friede; Jörg Schnitker

Book ID: 119192875
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 446 KB
Volume: 2
Category: Article
ISSN: 2210-5336
DOI: 10.1016/j.baga.2012.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Symptomatic efficacy and safety of diace

Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials

✍ E.M. Bartels; H. Bliddal; P.K. Schøndorff; R.D. Altman; W. Zhang; R. Christensen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Clinical experience on the role and sign

Clinical experience on the role and significance of selegiline in the treatment of Parkinson's disease

📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Pramipexole for the treatment of depress

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

✍ Paolo Barone; Werner Poewe; Stefan Albrecht; Catherine Debieuvre; Dan Massey; Ol 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 219 KB

Donepezil for the symptomatic treatment

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

✍ Anne Whitehead; Carlos Perdomo; Raymond D. Pratt; Jacqueline Birks; Gordon K. Wi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views

## Abstract ## Background The objective was to evaluate the efficacy and tolerability of donepezil (5 and 10 mg/day) compared with placebo in alleviating manifestations of mild to moderate Alzheimer's disease (AD). ## Method A systematic review of individual patient data from Phase II and III do

The effect of pramipexole on mood and mo

The effect of pramipexole on mood and motivational symptoms in parkinson's disease: A meta-analysis of placebo-controlled studies

✍ Albert F.G. Leentjens; Jürgen Koester; Barbara Fruh; D. Toby S. Shephard; Paolo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 857 KB

The efficacy and safety of risperidone i

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials

✍ Ira Katz; Peter-Paul de Deyn; Jacobo Mintzer; Andrew Greenspan; Young Zhu; Henry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Abstract ## Background Dementia typically includes behavioral and psychological symptoms of dementia (BPSD) as well as cognitive decline. Psychosis of Alzheimer's disease (AD) is a specific component of AD, characterized by delusions, misidentifications, and hallucinations. ## Methods This st